Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.

Published in: Dermatology and therapy (2022)

Vaccination against HZ with RZV is cost-effective compared with no vaccination in Japanese adults aged 65 years.

Keyphrases